Загрузка...
非小细胞肺癌吉西他滨药物耐药相关基因研究进展
With the development of pharmacogenomics and pharmacogenetics, personal therapy based on genes has become one of the most effective ways to enhance chemotherapeutic effect on non-small cell lung cancer (NSCLC) patients. Much attention has been paid to validate the predictive biomarkers of chemothera...
Сохранить в:
| Опубликовано в: : | Zhongguo Fei Ai Za Zhi |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
中国肺癌杂志编辑部
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000321/ https://ncbi.nlm.nih.gov/pubmed/21569648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2011.05.08 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|